Our transcriptomic analysis of the CRISPR-CAS9 genome edited Vimentin-RFP knock in TNBC cell line deciphered several differentially regulated genes and pathways that are involved in the EMT of these highly malignant breast cancer cells which could be of use for both diagnostic, prognostic, and therapeutic targets for future drug design and development. Here, VIM is linked to breast cancer.